BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tian Y, Zhang J, Yan S, Qiu L, Li Z. FATS expression is associated with cisplatin sensitivity in non small cell lung cancer. Lung Cancer 2012;76:416-22. [DOI: 10.1016/j.lungcan.2011.11.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Zhang L, Zhang K, Zhang J, Zhu J, Xi Q, Wang H, Zhang Z, Cheng Y, Yang G, Liu H, Guo X, Zhou D, Xue Z, Li Y, Zhang Q, Da Y, Liu L, Yin Z, Yao Z, Zhang R. Loss of fragile site-associated tumor suppressor promotes antitumor immunity via macrophage polarization. Nat Commun 2021;12:4300. [PMID: 34262035 DOI: 10.1038/s41467-021-24610-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
2 Qiu L, Hu L, Wang H, Li J, Ruan X, Sun B, Zhi J, Zheng X, Gu L, Gao M, Kong P, Zhang J. FATS regulates polyamine biosynthesis by promoting ODC degradation in an ERβ-dependent manner in non-small-cell lung cancer. Cell Death Dis 2020;11:839. [PMID: 33037185 DOI: 10.1038/s41419-020-03052-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wu X, Gao X, Xing X, Wen X, Li Z, Ji J. The T-Cell-Inflammation Status Can Predict Outcomes of Adjuvant Chemotherapy in Patients with Gastric Cancer. Ann Surg Oncol 2021;28:1407-16. [PMID: 32767226 DOI: 10.1245/s10434-020-09005-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Hunter FW, Devaux JBL, Meng F, Hong CR, Khan A, Tsai P, Ketela TW, Sharma I, Kakadia PM, Marastoni S, Shalev Z, Hickey AJR, Print CG, Bohlander SK, Hart CP, Wouters BG, Wilson WR. Functional CRISPR and shRNA Screens Identify Involvement of Mitochondrial Electron Transport in the Activation of Evofosfamide. Mol Pharmacol 2019;95:638-51. [PMID: 30979813 DOI: 10.1124/mol.118.115196] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
5 Zhang J, Wu N, Zhang T, Sun T, Su Y, Zhao J, Mu K, Jin Z, Gao M, Liu J, Gu L. The value of FATS expression in predicting sensitivity to radiotherapy in breast cancer. Oncotarget 2017;8:38491-500. [PMID: 28402275 DOI: 10.18632/oncotarget.16630] [Reference Citation Analysis]
6 Kiartivich S, Wei Y, Liu J, Soiampornkul R, Li M, Zhang H, Dong J. Regulation of cytotoxicity and apoptosis-associated pathways contributes to the enhancement of efficacy of cisplatin by baicalein adjuvant in human A549 lung cancer cells. Oncol Lett 2017;13:2799-804. [PMID: 28454469 DOI: 10.3892/ol.2017.5746] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
7 Song F, Zhang J, Qiu L, Zhao Y, Xing P, Lu J, Chen K, Li Z. A functional genetic variant in fragile-site gene FATS modulates the risk of breast cancer in triparous women. BMC Cancer 2015;15:559. [PMID: 26223354 DOI: 10.1186/s12885-015-1570-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
8 Yan S, Qiu L, Ma K, Zhang X, Zhao Y, Zhang J, Li X, Hao X, Li Z. FATS is an E2-independent ubiquitin ligase that stabilizes p53 and promotes its activation in response to DNA damage. Oncogene 2014;33:5424-33. [PMID: 24240685 DOI: 10.1038/onc.2013.494] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
9 Ma K, Qiu L, Mrasek K, Zhang J, Liehr T, Quintana LG, Li Z. Common fragile sites: genomic hotspots of DNA damage and carcinogenesis. Int J Mol Sci 2012;13:11974-99. [PMID: 23109895 DOI: 10.3390/ijms130911974] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 4.7] [Reference Citation Analysis]